BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Sudeep Pharma Ltd IPO: Check Subscription Status & Key Highlights

Sudeep Pharma Ltd has opened its IPO for subscription, drawing strong attention from retail and NII investors today. The issue offers a mix of growth potential and sector stability, with early bidding trends providing a clear picture of investor sentiment. The IPO has already seen a 1.42x overall subscription, driven largely by non-institutional participation.

In this blog, we break down the day-wise subscription numbers, investor category trends, IPO details, and utilisation of proceeds. You can also review more insights in the Sudeep Pharma Ltd IPO page for deeper understanding.

Sudeep Pharma Ltd IPO Subscription Status

Sudeep Pharma Ltd IPO recorded a 1.42x overall subscription today (as of Nov 21, 2025). Retail participation stood strong at 1.51x, while NII bids reached 3.00x, reflecting high demand from HNI investors. QIB (excluding anchor) participation remained muted at 0.09x, which is typical today as institutional investors often bid closer to closing day.

The momentum today suggests increasing traction across categories as the issue progresses.

Subscription Table

Investor Category

Subscription (times)

Shares Offered*

Shares bid for

Total Amount (Rs Cr.)*

Anchor Investors

1

45,27,823

45,27,823

268.500

QIB (Ex Anchor)

0.09

30,18,553

2,69,925

16.007

Non-Institutional Buyers

3.00

22,63,912

67,93,800

402.872

  bNII (bids above ₹10L)

2.75

15,09,275

41,45,775

245.844

  sNII (bids below ₹10L)

3.51

7,54,637

26,48,025

157.028

Retail Investors

1.51

52,82,462

79,51,350

471.515

Total **

1.42

1,05,64,927

1,50,15,075

890.394

Total Applications: 2,56,512 *Calculated at upper price band.

Sudeep Pharma Ltd – IPO Details

Sudeep Pharma Ltd IPO is a public offering of 1.51 crore equity shares, structured to attract diverse investor participation. Retail investors have been allocated 0.53 crore shares, while QIBs receive the largest portion at 0.75 crore shares, making up 50% of the issue size. NII investors hold a 15% allocation, divided into sNII and bNII categories for varied bidding preferences.

The IPO aims to support the company’s expansion plans and strengthen operational capabilities. With a total issue size of ₹895 crore, the offering positions Sudeep Pharma for its next phase of growth.

Shares Offered Breakdown

Category

Shares Offered

Amount (Rs Cr)

Size (%)

Anchor Investor

45,27,823

268.50

30.00%

QIB

75,46,376

447.50

50.00%

NII

22,63,912

134.25

15.00%

bNII (bids above ₹10L)

15,09,275

89.50

10.00%

sNII (bids below ₹10L)

7,54,637

44.75

5.00%

Retail

52,82,462

313.25

35.00%

Total

1,50,92,750

895.00

100%

Utilisation of Proceeds

  • Funding expansion and capacity enhancement

  • Strengthening working capital requirements

  • Investment in R&D and process optimisation

  • General corporate purposes

Sudeep Pharma Ltd IPO Anchor Investor Allocation

Below is the anchor allocation structure as disclosed:

Particulars

Details

Anchor Investor Bid Opening Date

Nov 20, 2025

Anchor Price

₹593.00 per share

Total Shares Allotted

45,27,823

Allocation as % of QIB Portion

Shares Locked for 30 Days

0

Shares Locked for 90 Days

0

Click here to check out recently closed IPO

Conclusion

The Sudeep Pharma Ltd IPO has begun on a positive note, especially with strong retail and NII participation shaping early demand. While QIB bids remain moderate today, institutional activity often accelerates closer to closing, making the upcoming days important to watch.

Overall, the IPO’s structure, anchor involvement, and subscription trends reflect healthy market interest. Investors can track day-wise updates to understand how the bidding pattern evolves across categories.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Sudeep Pharma Ltd IPO.  

Published Date : 21 Nov 2025

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,600+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|